Guardian Pharmacy Services, Inc. 8-K

What Happened

• Guardian Pharmacy Services, Inc. (GRDN) filed an 8-K on June 22, 2026 announcing management changes. Longtime Executive Vice President of Sales & Operations Kendall Forbes will retire effective July 1, 2026, and will remain employed through August 31, 2026 to assist with the transition. On July 1, 2026, current Executive Vice President and Chief Financial Officer David Morris will move to Executive Vice President and Chief Operating Officer, and Senior Vice President, Finance Will Mudd (age 47) will be promoted to Senior Vice President and Chief Financial Officer.

Key Details

• Filing date: June 22, 2026; effective date for changes: July 1, 2026.
• Kendall Forbes will be paid one-half of his current monthly base salary and receive customary health and welfare benefits for the transition period July 1–August 31, 2026.
• David Morris (age 63) has been CFO since the company’s founding in 2004 and a director since 2021; his background includes prior CFO and PBM leadership roles and a B.S. in Accounting from the University of Alabama.
• Will Mudd has been SVP, Finance since 2012, will not receive additional compensation for the promotion, and will continue to participate in the company’s executive compensation programs on the same terms as other executives.
• The company disclosed no family relationships, related arrangements, or transactions requiring disclosure under Regulation S-K for these appointments.

Why It Matters

• Leadership changes affect who runs the company’s finance and operations functions. Investors should note the continuity in management (internal promotions and long-tenured executives) and the defined transition plan for Forbes.
• The promotion of the finance lead without extra pay suggests continuity in compensation expense, while the temporary transition pay for Forbes is modest and time-limited.
• These are operational/management disclosures (Item 5.02) rather than financial results; investors may watch for any future filings or commentary on strategy or guidance tied to the new COO and CFO roles.